Belicha-Villanueva Alan, Riddell Jonah, Bangia Naveen, Gollnick Sandra O
Department of Immunology, Elm and Carlton Sts., Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Lasers Surg Med. 2012 Jan;44(1):60-8. doi: 10.1002/lsm.21160. Epub 2012 Jan 3.
Photodynamic therapy (PDT) is FDA-approved anti-cancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumor-specific immune response that is dependent on cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. The cytolytic potential of CTLs and NK cells is mediated by the ability of these cells to recognize major histocompatibility complex (MHC) class I and MHC class I-related molecules. The MHC class I-related molecules MICA and MICB are induced by oxidative stress and have been reported to activate NK cells and co-stimulate CD8(+) T cells. The purpose of this study was to examine the effect of PDT on tumor cell expression of MHC classes I and II-related molecules in vivo and in vitro.
STUDY DESIGN/MATERIALS AND METHODS: Human colon carcinoma Colo205 cells and murine CT26 tumors were treated with 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH)-PDT at various doses. MHC classes I and I-related molecule expression following treatment of Colo205 cells was temporally examined by flow cytometry using antibodies specific for components of MHC class I molecules and by quantitative PCR using specific primers. Expression of MHC class I-related molecules following HPPH-based PDT (HPPH-PDT) of murine tumors was monitored using a chimeric NKG2D receptor.
In vitro HPPH-PDT significantly induces MICA in Colo205 cells, but had no effect on MHC class I molecule expression. PDT also induced expression of NKG2D ligands (NKG2DL) following in vivo HPPH-PDT of a murine tumor. Induction of MICA corresponded to increased NK killing of PDT-treated tumor cells.
PDT induction of MICA on human tumor cells and increased expression of NKG2DL by murine tumors following PDT may play a role in PDT induction of anti-tumor immunity. This conclusion is supported by our results demonstrating that tumor cells have increased sensitivity to NK cell lysis following PDT.
光动力疗法(PDT)是一种经美国食品药品监督管理局(FDA)批准的抗癌方法,可用于消除早期疾病以及缓解晚期疾病症状。PDT的疗效部分取决于引发肿瘤特异性免疫反应,而这种反应依赖于细胞毒性T淋巴细胞(CTL)和自然杀伤(NK)细胞。CTL和NK细胞的细胞溶解潜能是由这些细胞识别主要组织相容性复合体(MHC)I类和MHC I类相关分子的能力介导的。MHC I类相关分子MICA和MICB由氧化应激诱导产生,据报道可激活NK细胞并共刺激CD8(+) T细胞。本研究的目的是在体内和体外研究PDT对肿瘤细胞MHC I类和II类相关分子表达的影响。
研究设计/材料与方法:用不同剂量的2-[1-己氧基乙基]-2-去乙烯基焦脱镁叶绿酸-a(HPPH)-PDT处理人结肠癌Colo205细胞和小鼠CT26肿瘤。使用针对MHC I类分子成分的特异性抗体,通过流式细胞术对Colo205细胞处理后的MHC I类和I类相关分子表达进行时间检测,并使用特异性引物通过定量PCR进行检测。使用嵌合NKG2D受体监测基于HPPH的光动力疗法(HPPH-PDT)处理小鼠肿瘤后MHC I类相关分子的表达。
体外HPPH-PDT显著诱导Colo205细胞中MICA的表达,但对MHC I类分子表达无影响。PDT在体内对小鼠肿瘤进行HPPH-PDT后,也诱导了NKG2D配体(NKG2DL)的表达。MICA的诱导与PDT处理的肿瘤细胞的NK杀伤增加相对应。
PDT诱导人肿瘤细胞上的MICA以及PDT后小鼠肿瘤中NKG2DL表达增加可能在PDT诱导的抗肿瘤免疫中发挥作用。我们的结果表明肿瘤细胞在PDT后对NK细胞裂解的敏感性增加,这支持了这一结论。